NCT00657176View on ClinicalTrials.gov

An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

June 30, 2009

Conditions
Solid Tumor
Interventions
DRUG

OPB-31121

"* 100mg tablet~* oral administration, Qd"

Trial Locations (1)

110-744

RECRUITING

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY